John C. Ruckdeschel, MD, FACP, FCCP

John Ruckdeschel resized

Specialties

  • Hematology Oncology

Treatment Focus

Medical Oncology, Thoracic Oncology

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427
  • Fox Chase Cancer Center - Voorhees
    502 Centennial Blvd
    Suite 7
    Voorhees, NJ 08043
    Phone: 888-369-2427

Educational Background

  • Rensselaer Polytechnic Institute, Troy, NY - B.Sc. Biology 1967
  • Albany Medical College, Albany, NY - M.D. 1971
  • Foundation for Advanced Education in the Sciences, NIH 1973, 1983 – 1984
  • Intermountain Advanced Training Program in Clinical Practice Improvement
  • Institute for Health Care Delivery Research, Salt Lake City, UT 84103

Certifications

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Medical Oncology

Honors & Awards

  • Fellow, Southern Society of Clinical Investigation 2018-2020
  • St. George Award from American Cancer Society 2018
  • Distinguished John Hopkins School of Medicine Alumni Award 2009
  • Michigan Cancer Consortium Spirit of Collaboration Award 2007
  • Hour Magazine Top Doctors in Detroit 2006
  • Best Doctors in America 1993 –
  • America's Top Doctors 2000 -
  • Honorary Member, USF Golden Key International Honor Society 2001
  • Distinguished Southern Oncologist Award 2001
  • Tampa Bay Magazine’s “Doctors Chosen by Doctors” 2001
  • Exemplary Alumni Award, Albany Medical College, Albany, NY 2000
  • Florida Medical Business Healthcare Physician Business Leadership Award 2000
  • Town and Gown Community Service Award 1999
  • The Medical Business Top 25: The Most Influential Physicians in Tampa Bay 1998
  • Who’s Who in Medicine and Healthcare 1996
  • Rensselaer Alumni Association Fellows Award - Biology 1996
  • Excel Award for Excellence in Communication Leadership 1994
  • Who’s Who in Science and Engineering 1991
  • Sigma Xi 1986 -2002

Selected Publications

  1. Wang Y, Rishi AK, Puliyappadamba VT, Sharma S, Yang H, Tarca A, Dou QP, Lonardo F, Ruckdeschel JC, Pass HI, Wali A. Targeted Proteasome Inhibition by Velcade Induces Apoptosis in Human Mesothelioma and Breast Cancer Cell Lines. Cancer Chemother Pharmacol. 2010:66:455-66.
  2. Schneider BJ, Kalemkerian GP, Ramnath N, Kraut MJ, Wozniak AJ, Worden FP, Ruckdeschel JC, Zhang X, Chen W, Gadgeel SM. Phase II Trial of Imatinib Maintenance Therapy After Irinotecan and Cisplatin in Patients with c-Kit-positive, Extensive-Stage Small-Cell Lung Cancer. Clin Lung Cancer. 2010; 11:223-7.169.
  3. Cline RJ, Orom H, Berry-Bobovski L, Hernandez T, Black CB, Schwartz AG, Ruckdeschel JC. Community-Level Social Support Responses in a Slow-Motion Technological Disaster: The Case of Libby, Montana. AM J Community Psychol. 2010; 46: 1-18.
  4. Turner JT, Khoury JD, Ruckdeschel JC. Granulomatous Solitary Pulmonary Nodule. J Bronchol Intervent Pulmonol. 2011; 18:111.
  5. Soubani AO, Ruckdeschel JC, The Outcome of Medical Intensive Care for Lung Cancer Patients: The Case for Optimism. J Thorac Oncol, 2011; 6:633-8.
  6. Gadgeel SW, Ruckdeschel JC, Patel, BB, Wozniak A, Konski A, Valdivieso M, Hackstock D, Chen W, Belzer K, Marquette L, Turrisi A. Phase II Study of Pemetrexed and Cisplatin, with Chest Radiotherapy Followed by Docetaxel in Patients with Stage III Non-Small Cell Lung Cancer (NSCLC) Patients. J Thorac Oncol 2011: 6; 927-33.
  7. Northouse LL, Mood DW, Schafenacker A, Kalemkerian G, Zalupski M, LoRusso P, Hayes DF, Hussain M, Ruckdeschel JC, Fendrick MA, Trask PC, Ronis DL, Kershaw T. Randomized Clinical Trial of a Brief and Extensive Dyadic Intervention for Advanced Cancer Patients and Their Family Caregivers. Psycho- Oncology 2013;22: 555-63.
  8. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston M, Goodman G, Clamon G,Okawara G, Marks R, Frechette E, McCaskill-Stevens W, Lippman SM, Ruckdeschel JC, and Khuri FR. Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non-Small-Cell Lung Cancer (ECOG 5597) J. Clin Oncol2013, 31:4179-85.Krug LM, Wozniak AJ, Kindler HL, Feld R, Koczywas M, Morero JL, Rodriguez C, Ros HJ, Bauman JE, Orlov SV, Ruckdeschel JC, Mita AC, Fein L, He X, Hall HR, Kawabe T, Sharma S. Randomized Phase II Trial of Pemetrexed/Cisplatin with or without CBP501 in Patients with Advanced Malignant Pleural Mesothelioma Lung Cancer. 2014 Sep; 85(3):429-34.
  9. Hahn EE, Tang T, Lee JS, Munoz-Plaza C, Adesina JO, Shen E, Rowley B, Maeda JL, Mosen DM, Ruckdeschel JC, Gould MK. Use of Imaging for Staging of Early-Stage Breast Cancer in Two Integrated Health Care Systems: Adherence with a Choosing Wisely Recommendation. J Oncol Pract. 2015 May;11(3): e320-8. Epub 2015 Apr 2
  10. Hahn EE, Tang T, Lee JS, Munoz-Plaza CE, Shen E, Rowley B, Maeda JL, Mosen DM, Ruckdeschel JC, Gould MK. Use of Posttreatment Imaging and Biomarkers in Survivors of Early-Stage Breast Cancer: Inappropriate Surveillance or Necessary Care? Cancer. 2016 Mar 15;122(6):908-16. Epub 2015 Dec 9.
  11. Miller AT, Kruger P, Conner K, Robertson T, Rowley B, Sause W, Ruckdeschel JC, Blagev DP. Initial Outcomes of a Lung Cancer Screening Program in an Integrated Community Health System.J Am Coll Radiol. 2016 Jun;13(6):733-7. Epub 2016 Apr 28.
  12. Schneider BJ, Kalemkerian GP, Gadgeel SM, Valdivieso M, Hackstock DM, Chen W, Heilbrun LK, Ruckdeschel JC, Wozniak AJ. Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients with Advanced, Non-Small-cell Lung Cancer. Clin Lung Cancer. 2017 May;18(3):299-302.
  13. Ruckdeschel J. A Cancer Center and Research Institute at the University of Mississippi Medical Center. (editorial) Arch Pathol Lab Med. 2020 Feb;144(2):148-149
  14. Hamid A, Anker M, Ruckdeschel JC, Khan MS, Tharwani A, Oshunbade AA, Kipchumba RK, Thigpen SC, Anker SD, Fonarow GC, Hall, MD, and Butler J. Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials. J Amer Heart Assoc. 2022. 11; e025206.
  15. Ruckdeschel JC, Riley M, Parsatharathy S, Chamarthi R, Rajagopal C, Hsu HS, and Driscoll C. Unstructured Data Are Superior to Structured Data for Eliciting Quantitative Smoking History from the Electronic Health Record. 2023. JCO Clin Cancer Inform 7: e2200155.

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...
Resize Text